Timothy A. Driscoll

Timothy A. Driscoll

Pediatrics

2301 Erwin Rd
Durham, NC 27710

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 29, 2026

Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes.

Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes.

Journal: Bone marrow transplantation

Published: August 21, 2025

Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.

Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.

Journal: Stem cells translational medicine

Published: May 15, 2025

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.

Journal: Blood advances

Published: January 28, 2025

A reduced-toxicity myeloablative conditioning approach for hematopoietic cell transplant in juvenile myelomonocytic leukemia.

A reduced-toxicity myeloablative conditioning approach for hematopoietic cell transplant in juvenile myelomonocytic leukemia.

Journal: Frontiers in oncology

Published: December 07, 2024

Newborn Screening for Hurler Syndrome Facilitates Early Transplant and Good Outcomes.

Newborn Screening for Hurler Syndrome Facilitates Early Transplant and Good Outcomes.

Journal: Pediatric neurology

Published: July 27, 2024

Safety and feasibility of umbilical cord blood transplantation in children with neuronal ceroid lipofuscinosis: a retrospective study.

Safety and feasibility of umbilical cord blood transplantation in children with neuronal ceroid lipofuscinosis: a retrospective study.

Journal: Stem cells translational medicine

Published: May 31, 2024

Mediport use as an acceptable standard for CAR T cell infusion.

Mediport use as an acceptable standard for CAR T cell infusion.

Journal: Frontiers in immunology

Published: June 12, 2023

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.

Journal: Bone marrow transplantation

Published: May 02, 2023

Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease.

Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease.

Journal: Pediatric dermatology

Published: March 02, 2022

Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.

Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.

Journal: Journal for immunotherapy of cancer

Published: June 10, 2021

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: March 22, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026